Nanobiotix S.A. (NANO)
Euronext
34.14
-3.90 (-10.25%)
Closed
Aug 24, 2026
Day's Range
33.7037.00
52 wk Range
6.9647.66
Financial Statements - NANO - Nanobiotix S.A.
Revenue
29.64M▲ 355.3%
Net Income
-23.96M▲ 64.8%Net Margin -80.8%
EBITDA
-8.83M▲ 85.6%
Free Cash Flow
-33.96M▼ 66.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 29.64M | -11.61M | 30.05M | 0 | 10K | 50K |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -10.81M | -68.39M | -26.77M | -46.70M | -52.57M | -36.42M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -3.23M | 2.98M | -6.32M | 2.10M | 6.23M | -1.59M |
| Pre Tax Income | -23.95M | -68.03M | -39.58M | -57.03M | -46.99M | -33.58M |
| Income Tax | 3K | 101K | 120K | 10K | 5K | 9K |
| Net Income | -23.96M | -68.13M | -39.70M | -57.04M | -47M | -33.59M |
| EPS Basic | - | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 |
| EPS Diluted | - | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 |
| Basic Shares Outstanding | - | 47.26M | 36.92M | 34.78M | 34.73M | 24.38M |
| Diluted Shares Outstanding | - | 47.26M | 36.92M | 34.78M | 34.73M | 24.38M |
| Ebit | -13.56M | -59.94M | -31.59M | -51.19M | -46.32M | -33.24M |
| Ebitda | -8.83M | -61.31M | -23.76M | -51.80M | -51M | -29.90M |
| Net Income Continuous Operations | -23.96M | -68.13M | -39.70M | -57.04M | -47M | -33.59M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
